This injectable medication is well-known for working on two important receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent Tirzepatide mimics the effects of GLP-1, a long-acting version of a natural hormone that helps people feel full when they eat
According to FDA prescribing information and clinical trial data, common side effects include nausea (occurring in 1544% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation
And in the compounded semaglutide market, it often screams
Atrial fibrillation is strongly associated with obesity and metabolic dysfunction, and its reduction with semaglutide treatment suggests deep physiological remodeling beyond simple weight loss
National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894, Treasure Island (FL): StatPearls Publishing (2023)